Inverse Expression of Cdk4 and p16 in Epithelial Ovarian Tumors
- 1 November 2000
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 79 (2), 230-237
- https://doi.org/10.1006/gyno.2000.5961
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesisOncogene, 1999
- Differences inp16Gene Methylation and Expression in Benign and Malignant Ovarian TumorsGynecologic Oncology, 1999
- No Evidence Exists for Methylation Inactivation of thep16Tumor Suppressor Gene in Ovarian CarcinogenesisGynecologic Oncology, 1998
- Rare mutations and no hypermethylation at theCDKN2A locus in epithelial ovarian tumoursInternational Journal of Cancer, 1997
- Cancer Cell CyclesScience, 1996
- Loh and mutation analysis of CDKN2 in primary human ovarian cancersInternational Journal of Cancer, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- G1 phase progression: Cycling on cueCell, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993